Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
JTO Clinical and Research Reports
|
September 30, 2021
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial
Jordi Remon, Benjamin Besse, Alexandra Leary, et al.
Plos One
|
April 26, 2021
Validity and reliability of the Spanish version of the "Wijma Delivery Expectancy/Experience Questionnaire" (W-DEQ-B)
Juan Roldán-Merino, Celia Maria Ortega-Cejas, Teresa Lluch-Canut, et al.
British Journal of Cancer
|
June 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature
Solenn Barraud, Sophie Vacher, Camille Schiffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study
Nicolas Penel, Binh Nguyen Bui, Jacques-Olivier Bay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2021
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
Mario Campone, Thomas Bachelot, Isabelle Treilleux, et al.
European Journal of Heart Failure
|
August 17, 2025
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC
Guillaume Baudry, Maria Generosa Crespo-Leiro, Clément Delmas, et al.
British Journal of Cancer
|
January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
The Lancet. Oncology
|
February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 11, 2021
Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19
Salomon Martin, Sandra Fuentes, Catalina Sanchez, et al.
Cancer Research
|
March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors
Yanyan Cai, Guotai Xu, Fan Wu, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
JTO Clinical and Research Reports
|
September 30, 2021
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial
Jordi Remon, Benjamin Besse, Alexandra Leary, et al.
Plos One
|
April 26, 2021
Validity and reliability of the Spanish version of the "Wijma Delivery Expectancy/Experience Questionnaire" (W-DEQ-B)
Juan Roldán-Merino, Celia Maria Ortega-Cejas, Teresa Lluch-Canut, et al.
British Journal of Cancer
|
June 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature
Solenn Barraud, Sophie Vacher, Camille Schiffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study
Nicolas Penel, Binh Nguyen Bui, Jacques-Olivier Bay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2021
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
Mario Campone, Thomas Bachelot, Isabelle Treilleux, et al.
European Journal of Heart Failure
|
August 17, 2025
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC
Guillaume Baudry, Maria Generosa Crespo-Leiro, Clément Delmas, et al.
British Journal of Cancer
|
January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
The Lancet. Oncology
|
February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 11, 2021
Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19
Salomon Martin, Sandra Fuentes, Catalina Sanchez, et al.
Cancer Research
|
March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors
Yanyan Cai, Guotai Xu, Fan Wu, et al.
Page
of 8